Wolf, P; Weger, W; Richter, L; Mlynek, A; Sator, P; Saxinger, W; Ratzinger, G; Kolli, C; Painsi, C; Bangert, C; Tatarski, R; Schutz-Bergmayr, M; Ponholzer, P; Trautinger, F; Strohal, R; Mullegger, R; Inzinger, M; Lichem, R; Salmhofer, W; Quehenberger, F.
Switching or restarting of tumour necrosis factor-alpha inhibitors after interruption under daily-life conditions: efficacy report from the Austrian Psoriasis Registry (PsoRA)
BRIT J DERMATOL. 2017; 177(5): E250-E250.
[Oral Communication]
Web of Science